Both speakers agreed that last year's SERVE-HF trial, published in the New England Journal of Medicine, was the end of adaptive servo ventilation (ASV) as a treatment for heart ... failure patients who have Cheyne-Stokes breathing.
Treat blood pressure? Not worth it. Treat congestive heart failure? I guess I can fork out the money.
By forgoing or delaying physician visits or therapies, the uninsured are more likely to die from congestive heart failure, myocardial infarctions or strokes than are those with insurance, resulting in as
1.34) for heart failure; 1.14 (95% CI, 1.05-1.24) for death; and 1.18 (95% CI, 1.12-1.23) for the composite of myocardial infarction, stroke, ... heart failure or death.
Its symptoms are fever, headache, cough, sore throat, runny nose, sometimes also heart failure, respiratory failure and brain dysfunction.
But diuretics are primarily symptom relief medications. I often ask students and residents to write this sentence, memorize it, and use it: “The purpose of diuretic therapy in systolic heart failure ... And yet “heart failure” is the single most
Read about why management of diuretic medications in patients with heart failure can often be a complicated proposition. ... Yancy, MD, MSc, MACP, which addressed the question of whether heart failure is different in African-American patients.
many exclusions: prior stroke, end-stage kidney disease, a prior cardiovascular procedure, and symptomatic heart failure within the last 6 months, among others. ... While the payoff in terms of reduced heart failure and cardiovascular death was clear-cut,
pathologies. When sending home a patient after treatment for congestive heart failure, the issue is not just the status of the heart failure but of the person.
Systolic heart failure, home oxygen, the serum ascites albumin gradient, lactic acidosis and the use of biventricular pacing all benefit from a basic science understanding.